{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:47:14Z","timestamp":1776120434498,"version":"3.50.1"},"publisher-location":"Berlin, Heidelberg","reference-count":35,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642451942","type":"print"},{"value":"9783642451959","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-642-45195-9_11","type":"book-chapter","created":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T17:21:52Z","timestamp":1392657712000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Aspirin and Prostate Cancer Prevention"],"prefix":"10.1007","author":[{"given":"Cristina","family":"Bosetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvano","family":"Gallus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,16]]},"reference":[{"issue":"5","key":"11_CR1","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","volume":"13","author":"AM Algra","year":"2012","unstructured":"Algra AM, Rothwell PM (2012) Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 13(5):518\u2013527","journal-title":"Lancet Oncol"},{"issue":"2","key":"11_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","volume":"9","author":"NM Bambace","year":"2011","unstructured":"Bambace NM, Holmes CE (2011) The platelet contribution to cancer progression. J Thromb Haemost 9(2):237\u2013249","journal-title":"J Thromb Haemost"},{"issue":"1","key":"11_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/01.cej.0000180665.04335.de","volume":"15","author":"C Bosetti","year":"2006","unstructured":"Bosetti C, Talamini R, Negri E, Franceschi S, Montella M, La Vecchia C (2006) Aspirin and the risk of prostate cancer. Eur J Cancer Prev 15(1):43\u201345","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"11_CR4","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1093\/annonc\/mds113","volume":"23","author":"C Bosetti","year":"2012","unstructured":"Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C (2012a) Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol 23(6):1403\u20131415","journal-title":"Ann Oncol"},{"issue":"2","key":"11_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrurol.2011.219","volume":"9","author":"C Bosetti","year":"2012","unstructured":"Bosetti C, Rosato V, Gallus S, La Vecchia C (2012b) Aspirin and urologic cancer risk: an update. Nat Rev Urol 9(2):102\u2013110","journal-title":"Nat Rev Urol"},{"issue":"12","key":"11_CR6","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1200\/JCO.2005.09.051","volume":"23","author":"JR Brown","year":"2005","unstructured":"Brown JR, DuBois RN (2005) COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 23(12):2840\u20132855","journal-title":"J Clin Oncol"},{"issue":"2","key":"11_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood-2004-02-0434","volume":"104","author":"E Camerer","year":"2004","unstructured":"Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR (2004) Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104(2):397\u2013401","journal-title":"Blood"},{"issue":"28","key":"11_CR8","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1200\/JCO.2011.41.0308","volume":"30","author":"KS Choe","year":"2012","unstructured":"Choe KS, Cowan JE, Chan JM, Carroll PR, D\u2019Amico AV, Liauw SL (2012) Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol 30(28):3540\u20133544","journal-title":"J Clin Oncol"},{"issue":"5","key":"11_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","volume":"10","author":"J Cuzick","year":"2009","unstructured":"Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P et al (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10(5):501\u2013507","journal-title":"Lancet Oncol"},{"issue":"2","key":"11_CR10","first-page":"130","volume":"12","author":"K Dasgupta","year":"2006","unstructured":"Dasgupta K, Di Cesar D, Ghosn J, Rajan R, Mahmud S, Rahme E (2006) Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence. Cancer J 12(2):130\u2013135","journal-title":"Cancer J"},{"issue":"10","key":"11_CR11","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/ijc.25811","volume":"128","author":"PK Dhillon","year":"2011","unstructured":"Dhillon PK, Kenfield SA, Stampfer MJ, Giovannucci EL (2011) Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988\u20132006. Int J Cancer 128(10):2444\u20132452","journal-title":"Int J Cancer"},{"issue":"10","key":"11_CR12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1158\/1940-6207.CAPR-12-0171","volume":"5","author":"PK Dhillon","year":"2012","unstructured":"Dhillon PK, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM (2012) Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort. Cancer Prev Res (Phila) 5(10):1223\u20131228","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9671","key":"11_CR13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(09)60243-9","volume":"373","author":"PC Elwood","year":"2009","unstructured":"Elwood PC, Gallagher AM, Duthie GG, Mur LA, Morgan G (2009) Aspirin, salicylates, and cancer. Lancet 373(9671):1301\u20131309","journal-title":"Lancet"},{"issue":"4","key":"11_CR14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1055-9965.649.13.4","volume":"13","author":"LA Garcia Rodriguez","year":"2004","unstructured":"Garcia Rodriguez LA, Gonzalez-Perez A (2004) Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. Cancer Epidemiol Biomarkers Prev 13(4):649\u2013653","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"11_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11(2):123\u2013134","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"11_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G","volume":"42","author":"S Gupta","year":"2000","unstructured":"Gupta S, Srivastava M, Ahmad N, Bostwick DG, Mukhtar H (2000) Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 42(1):73\u201378","journal-title":"Prostate"},{"issue":"5","key":"11_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1023\/A:1015788502099","volume":"13","author":"LA Habel","year":"2002","unstructured":"Habel LA, Zhao W, Stanford JL (2002) Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Control 13(5):427\u2013434","journal-title":"Cancer Control"},{"key":"11_CR18","doi-asserted-by":"crossref","unstructured":"Harris RE, Beebe-Donk J, Alshafie GA (2007) Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade (Chapter 9). In: Harris RE (ed) Inflammation in the pathogenesis of chronic diseases. Springer, New York, pp 193\u2013212","DOI":"10.1007\/1-4020-5688-5_9"},{"issue":"8","key":"11_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jnci\/djk132","volume":"99","author":"EJ Jacobs","year":"2007","unstructured":"Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle EE (2007) A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99(8):608\u2013615","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"11_CR20","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/jnci\/djs318","volume":"104","author":"EJ Jacobs","year":"2012","unstructured":"Jacobs EJ, Newton CC, Gapstur SM, Thun MJ (2012) Daily aspirin use and cancer mortality in a large US cohort. J Natl Cancer Inst 104(16):1208\u20131217","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"11_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/bjc.2011.289","volume":"105","author":"RE Langley","year":"2011","unstructured":"Langley RE, Burdett S, Tierney JF, Cafferty F, Parmar MK, Venning G (2011) Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Br J Cancer 105(8):1107\u20131113","journal-title":"Br J Cancer"},{"issue":"10","key":"11_CR22","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/aje\/kwj294","volume":"164","author":"X Liu","year":"2006","unstructured":"Liu X, Plummer SJ, Nock NL, Casey G, Witte JS (2006) Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha. Am J Epidemiol 164(10):984\u2013989","journal-title":"Am J Epidemiol"},{"issue":"7","key":"11_CR23","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/ijc.25186","volume":"127","author":"SM Mahmud","year":"2010","unstructured":"Mahmud SM, Franco EL, Aprikian AG (2010) Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis. Int J Cancer 127(7):1680\u20131691","journal-title":"Int J Cancer"},{"issue":"1","key":"11_CR24","doi-asserted-by":"publisher","first-page":"e16412","DOI":"10.1371\/journal.pone.0016412","volume":"6","author":"SM Mahmud","year":"2011","unstructured":"Mahmud SM, Franco EL, Turner D, Platt RW, Beck P, Skarsgard D et al (2011) Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study. PLoS ONE 6(1):e16412","journal-title":"PLoS ONE"},{"issue":"3","key":"11_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10552-005-0450-z","volume":"17","author":"RJ Menezes","year":"2006","unstructured":"Menezes RJ, Swede H, Niles R, Moysich KB (2006) Regular use of aspirin and prostate cancer risk (United States). Cancer Control 17(3):251\u2013256","journal-title":"Cancer Control"},{"issue":"3","key":"11_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ijc.11250","volume":"106","author":"L Perron","year":"2003","unstructured":"Perron L, Bairati I, Moore L, Meyer F (2003) Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer. Int J Cancer 106(3):409\u2013415","journal-title":"Int J Cancer"},{"issue":"9759","key":"11_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377(9759):31\u201341","journal-title":"Lancet"},{"issue":"9826","key":"11_CR28","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G et al (2012a) Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 379(9826):1602\u20131612","journal-title":"Lancet"},{"issue":"9826","key":"11_CR29","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z (2012b) Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 379(9826):1591\u20131601","journal-title":"Lancet"},{"issue":"5","key":"11_CR30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/aje\/kwq175","volume":"172","author":"CA Salinas","year":"2010","unstructured":"Salinas CA, Kwon EM, FitzGerald LM, Feng Z, Nelson PS, Ostrander EA et al (2010) Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. Am J Epidemiol 172(5):578\u2013590","journal-title":"Am J Epidemiol"},{"issue":"20","key":"11_CR31","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/jnci\/90.20.1529","volume":"90","author":"MM Taketo","year":"1998","unstructured":"Taketo MM (1998a) Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 90(20):1529\u20131536","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"11_CR32","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/jnci\/90.21.1609","volume":"90","author":"MM Taketo","year":"1998","unstructured":"Taketo MM (1998b) Cyclooxygenase-2 inhibitors in tumorigenesis (part II). J Natl Cancer Inst 90(21):1609\u20131620","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"11_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","volume":"94","author":"MJ Thun","year":"2002","unstructured":"Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94(4):252\u2013266","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"11_CR34","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ejca.2012.09.030","volume":"49","author":"T Veitonm\u00e4ki","year":"2013","unstructured":"Veitonm\u00e4ki T, Tammela TL, Auvinen A, Murtola TJ (2013) Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. Eur J Cancer 49(4):938\u2013945","journal-title":"Eur J Cancer"},{"issue":"3","key":"11_CR35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C","volume":"89","author":"R Yoshimura","year":"2000","unstructured":"Yoshimura R, Sano H, Masuda C, Kawamura M, Tsubouchi Y, Chargui J et al (2000) Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 89(3):589\u2013596","journal-title":"Cancer"}],"container-title":["Recent Results in Cancer Research","Prostate Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-45195-9_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:25:00Z","timestamp":1676373900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-45195-9_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783642451942","9783642451959"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-45195-9_11","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"16 February 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}